Kamada Ltd. (KMDA)
8.42
+0.18
(+2.18%)
USD |
NASDAQ |
Aug 24, 16:00
8.42
0.00 (0.00%)
After-Hours: 20:00
Kamada Market Cap : 485.79M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 475.40M |
| August 20, 2026 | 462.71M |
| August 19, 2026 | 455.21M |
| August 18, 2026 | 455.21M |
| August 17, 2026 | 447.71M |
| August 14, 2026 | 437.32M |
| August 13, 2026 | 418.86M |
| August 12, 2026 | 396.94M |
| August 11, 2026 | 409.05M |
| August 10, 2026 | 411.94M |
| August 07, 2026 | 419.38M |
| August 06, 2026 | 411.88M |
| August 05, 2026 | 414.19M |
| August 04, 2026 | 423.42M |
| August 03, 2026 | 417.07M |
| July 31, 2026 | 411.88M |
| July 30, 2026 | 409.57M |
| July 29, 2026 | 404.38M |
| July 28, 2026 | 407.26M |
| July 27, 2026 | 403.23M |
| July 24, 2026 | 407.26M |
| July 23, 2026 | 401.50M |
| July 22, 2026 | 404.38M |
| July 21, 2026 | 419.95M |
| July 20, 2026 | 408.99M |
| Date | Value |
|---|---|
| July 17, 2026 | 406.69M |
| July 16, 2026 | 398.61M |
| July 15, 2026 | 412.46M |
| July 14, 2026 | 419.38M |
| July 13, 2026 | 413.61M |
| July 10, 2026 | 410.72M |
| July 09, 2026 | 412.46M |
| July 08, 2026 | 419.95M |
| July 07, 2026 | 421.69M |
| July 06, 2026 | 432.07M |
| July 02, 2026 | 432.65M |
| July 01, 2026 | 433.80M |
| June 30, 2026 | 423.42M |
| June 29, 2026 | 424.57M |
| June 26, 2026 | 418.80M |
| June 25, 2026 | 414.19M |
| June 24, 2026 | 411.59M |
| June 23, 2026 | 411.30M |
| June 22, 2026 | 414.76M |
| June 18, 2026 | 421.69M |
| June 17, 2026 | 418.80M |
| June 16, 2026 | 430.34M |
| June 15, 2026 | 430.34M |
| June 12, 2026 | 429.18M |
| June 11, 2026 | 429.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 12.18M |
| XTL Biopharmaceuticals Ltd. | 5.985M |
| Can-Fite BioPharma Ltd. | 4.298M |
| Galmed Pharmaceuticals Ltd. | 3.316M |
| Revium Recovery, Inc. | 86.84M |
Market Cap Related Metrics
| PE Ratio | 22.06 |
| PS Ratio | 2.578 |
| PEG Ratio | 1.427 |
| Price to Book Value | 1.802 |
| Price to Free Cash Flow | 17.90 |
| Price | 8.42 |
| Earnings Yield | 4.53% |
| PEGY Ratio | 1.193 |
| Operating PE Ratio | 17.78 |
| Normalized PE Ratio | 21.50 |